Reposted by loscharlos
“It is possible that, on a 5-year horizon, you would be able to give a blood sample & we could say, ‘Yes, based on these 3 markers, we can confirm that you have #LongCovid & it is the autoimmune phenotype, for example, & these are the treatments we’re going to give you,’” — @putrinolab.bsky.social
thesicktimes.org
VIPER aims to fast track Long COVID biomarkers. Here’s how it works. - The Sick Times
Led by researchers at UCSF, the research program plans to validate promising candidates for noninvasive tests that can be used to advance clinical trials.